Unidad de Investigación Clínica de Tumores Hematológicos H12O-CNIO

Inicio | Investigación e innovación | Programas Científicos | Programa de Investigación Clínica | Unidad de Investigación Clínica de Tumores Hematológicos H12O-CNIO

“Este contenido se encuentra unicamente en inglés”

Joaquín Martínez
Joaquín Martínez Jefe de Grupo
T +34 917 328 000 (Ext )
jmartinezl@ext.cnio.es

Investigadores

  • Rosa María Ayala
  • María Calbacho
  • María Teresa Cedena
  • Francisco Javier De La Serna
  • Lucia Virginia Fernández
  • Miguel Gallardo
  • Carlos Grande
  • María Inmaculada Rapado
  • Antonia Rodríguez

Becarios Post-doctorales

  • Almudena García
  • María Linares
  • Ricardo Sánchez
  • Antonio Valeri

Becarios Pre-Doctorales

  • Sergio Algar
  • Isabel Cuenca
  • Jessica Encinas
  • Alejandra Leivas
  • Elena Maroto
  • María Luz Morales
  • María Alejandra Ortiz
  • Alba Rodríguez
  • Yanira Ruiz
  • Laura Sánchez

Técnicos de Laboratorio

  • Pedro Aguilar
  • Adrián Fernández
  • Alexandra Juárez
  • María Esther Onecha

The Haematological Malignancies Clinical Research Unit focuses on 3 main objectives:

  • Molecular research of haematological cancers: studying of cancer induced changes at the proteomic and genomic levels. We aim to: i) find new genomic and proteomics biomarkers for a better diagnosis of these haematological diseases; ii) detect new molecular alterations as predictors of response to a treatment, for example by studying minimal residual disease; and iii) study immune mechanisms of cancer control, with a special focus on NK cells.
  • In vitro & in vivo research: i) to establish the effects of new anticancer molecules in in vitro models of the disease; ii) to determine the mechanisms of resistance to anticancer drugs.
  • Clinical research: translate preclinical findings to the patients through a phase I clinical trials unit.

Subir